|
|
Article: Curis Seeking BMP Partner As Ortho Biotech Backs Out.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
Curis Inc.'s bone morphogenetic protein-7 for kidney disease could move along more quickly with another partner, now that longstanding licensee Ortho Biotech Products L.P. has terminated the deal. But all work on the compound is still preclinical, and Curis has just begun contacting potential collaborators.
In late 2002, Curis licensed the technology to the subsidiary of New Brunswick, N.J.-based Johnson & Johnson, centered on BMP-7, for all indications except repair or regeneration of local musculoskeletal tissue defects and dental defects, which are covered under a separate deal with Stryker Corp., of Kalamazoo, Mich. (See BioWorld ...
Related newspaper, magazine, and journal articles:
|
|
Article: CURIS RESTRUCTURING INCLUDES CUTTING PROGRAMS, ...
BIOWORLD Today;
February 19, 2002 ;
700+ words
... ... patients annually. (See BioWorld Today, Oct. 22, 2001 ... said OP-1 validates Curis' approach to development ... Cambridge. (See BioWorld Today, Feb. 16, 2001 ... communications for Curis, told BioWorld Today, "What we've done ...
|
|